Clinical Outcomes of Older Patients with Non-Variceal Upper Gastrointestinal Bleeding Taking Anti-Thrombotic or Non-Steroidal Anti-Inflammatory Agents

• Published in: The Turkish journal of gastroenterology 2023-09, Vol.34 (9), p.918-924
• Main Authors: Durak, Muhammed Bahaddin, Simsek, Cem, Yuksel, Ilhami
• Format: Article
• Language: English
• Subjects: Aged patients; Anticoagulants (Medicine); Drug therapy; Gastrointestinal bleeding; Gastrointestinal Endoscopy; Original; Patient outcomes
• ISSN: 1300-4948; 2148-5607
• DOI: 10.5152/tjg.2023.23226

Background/Aims: Non-variceal upper gastrointestinal bleeding is a well-established complication of non-steroidal anti-inflammatory drugs and anti-thrombotics. Both medication groups are frequently used by older populations and increase the incidence of non-variceal upper gastrointestinal bleeding; however, their impact on etiology and outcomes of non-variceal upper gastrointestinal bleeding has not been well defined. We aimed to compare the etiology and outcomes of non-variceal upper gastrointestinal bleeding in older patients who use anti-thrombotics and non-steroidal anti-inflammatory drugs or do not use either of them. Materials and Methods: This is a single-center prospective study of patients older than 65 years with non-variceal upper gastrointestinal bleeding. Endoscopic findings, laboratory values, blood transfusion, endoscopic treatment, re-bleeding, and 30-day mortality rates were recorded. Results: A total of 257 patients (median age 77.7 [+ or -] 8.2, 59% male) were included. Re-bleeding occurred in 25 (10%) and the 30-day mortality rate was 40 (16%). There was no statistically significant difference between patients using anti-thrombotics, non-steroidal anti-inflammatory drugs or non-users for blood transfusion (P = .46), endoscopic hemostasis (P = .39), re-bleeding (P = .09), and 30-day mortality (P = .45). Peptic ulcer was the most common etiology in all groups (124, 48%). Although the incidence of peptic ulcer was similar between drug users and anti-thrombotic users (P = .75), the incidence of peptic ulcer was significantly higher in patients using non-steroidal anti-inflammatory drugs than in patients who did not use drugs (P = .05). When the patients were analyzed as using antithrombotic drugs or non-steroidal anti-inflammatory drugs or neither, no statistically significant difference was found between ulcer location, ulcer number, and ulcer size. Conclusion: Non-variceal upper gastrointestinal bleeding increasingly occurs in older populations with several comorbidities; nonsteroidal anti-inflammatory drugs or anti-thrombotics do not seem to change the clinical outcomes among older patients with nonvariceal upper gastrointestinal bleeding. Keywords: Upper gastrointestinal bleeding, anti-thrombotic drugs, non-steroidal anti-inflammatory drugs